Debjit Chattopadhyay


Last quote by Debjit Chattopadhyay

If Sarepta does get the approval the stock is going to be meaningfully higher, probably in the $35 to $45 range. Else the stock could be in the $5
share this quote
May 23 2016
Debjit Chattopadhyay has been quoted 3 times. The one recent article where Debjit Chattopadhyay has been quoted is Sarepta shares sink as FDA staff stay sour on muscle drug. Most recently, Debjit Chattopadhyay was quoted as having said, “BioMarin's drug is dead. Eteplirsen is now dead. There is nothing in DMD for the foreseeable future.”.
Automatically powered by Storyzy
Take our quote verification challenge and find out !

Quotes by Debjit Chattopadhyay

Quote Verifier
Check if the quote you read on social networks is authentic
This webpage has been created by a robot: errors and absent quotes cannot be totally avoided

Quote :

Mistake :

Comments :